News und Analysen
Dexcom Reports First Quarter 2020 Financial Results
DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended March 31, 2020.
First Quarter 2020 and COVID-19 Pandemic Response Highlights:
-
Revenue grew 44%
Illumina’s Donation to the Africa Centre for Disease Control and Prevention Expands their Capability for Sequencing-Based COVID-19 Surveillance
Illumina, Inc. (NASDAQ: ILMN) is pleased to announce that the African Union Commission, on behalf of the Africa Center for Disease Control and Prevention (CDC), is receiving a $1.4 million donation
Illumina’s Donation to the Africa Centre for Disease Control and Prevention Expands their Capability for Sequencing-Based COVID-19 Surveillance
Illumina, Inc. (NASDAQ: ILMN) is pleased to announce that the African Union Commission, on behalf of the Africa Center for Disease Control and Prevention (CDC), is receiving a $1.4 million donation
Illumina’s Donation to the Africa Centre for Disease Control and Prevention Expands their Capability for Sequencing-Based COVID-19 Surveillance
Illumina, Inc. (NASDAQ: ILMN) is pleased to announce that the African Union Commission, on behalf of the Africa Center for Disease Control and Prevention (CDC), is receiving a $1.4 million donation
PFIZER REPORTS FIRST-QUARTER 2020 RESULTS
Pfizer Inc. (NYSE: PFE) reported financial results for first-quarter 2020, reaffirmed its 2020 financial guidance for revenues and Adjusted diluted EPS(3) and updated certain other components of
PFIZER REPORTS FIRST-QUARTER 2020 RESULTS
Pfizer Inc. (NYSE: PFE) reported financial results for first-quarter 2020, reaffirmed its 2020 financial guidance for revenues and Adjusted diluted EPS(3) and updated certain other components of
LivaNova Bi-Flow-Kanüle erhält CE-Zeichen für ECMO-Anwendungen
LivaNova PLC (NASDAQ:LIVN), ein marktführendes Unternehmen für Medizintechnik und Innovationen, gab heute bekannt, dass seine Bi-Flow-Kanüle für extrakorporale Membranoxygenierung (ECMO) die
EOS imaging Reports Its Full Year 2019 Results and First Quarter 2020 Revenues
Regulatory News:
EOS imaging (Paris:EOSI) (Euronext, FR0011191766 - EOSI - PEA-PME eligible), a leader in 2D/3D orthopedic medical imaging and software solutions for 3D anatomical modeling and
LivaNova Bi-Flow Cannula Receives CE Mark for ECMO Applications
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its Bi-Flow Extracorporeal Membrane Oxygenation (ECMO) cannula earned CE Mark approval for
Dexcom to Launch Patient Assistance Program for Current U.S. Customers Impacted by COVID-19 Pandemic
DexCom, Inc. (NASDAQ:DXCM), the leader in continuous glucose monitoring (CGM) systems for people with diabetes, announced today a new patient assistance program to aid current U.S. customers who
Dexcom to Launch Patient Assistance Program for Current U.S. Customers Impacted by COVID-19 Pandemic
DexCom, Inc. (NASDAQ:DXCM), the leader in continuous glucose monitoring (CGM) systems for people with diabetes, announced today a new patient assistance program to aid current U.S. customers who
Novocure Announces Presentation of EF-19 Post-approval Registry Trial Data Studying Optune as a Monotherapy for the Treatment of Recurrent GBM at the American Association for Cancer Research 2020 Virtual Annual Meeting I
Novocure (NASDAQ: NVCR) today announced that an abstract highlighting results from the EF-19 post-approval registry trial studying Optune for the treatment of recurrent GBM will be presented as a
Aurinia Appoints Joe Miller as Chief Financial Officer
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advancing voclosporin in multiple indications, today
Alphatec Holdings Terminates Tender Offer Agreement with EOS imaging
Regulatory News:
EOS imaging (Paris:EOSI) (Euronext, FR0011191766 - EOSI - Eligible PEA - PME) ("EOS"), a leader in 2D/3D orthopedic medical imaging and software solutions for 3D anatomical
Premier Inc. to Report Fiscal 2020 Third-Quarter Results and Host Conference Call Before Market Opens on May 5
Premier Inc. (NASDAQ: PINC) plans to report fiscal 2020 third-quarter financial results the morning of May 5, 2020, followed by a conference call at 8 a.m. ET to discuss the results.
Conference
GSK Presents New Data from the GARNET Study Demonstrating Potential of Dostarlimab to Treat a Subset of Women with Recurrent or Advanced Endometrial Cancer
GlaxoSmithKline plc (LSE/NYSE:GSK) today announced data from an updated analysis of the GARNET trial, which demonstrated that dostarlimab, an investigational anti-programmed death-1 (PD-1)
GSK Presents New Data from the GARNET Study Demonstrating Potential of Dostarlimab to Treat a Subset of Women with Recurrent or Advanced Endometrial Cancer
GlaxoSmithKline plc (LSE/NYSE:GSK) today announced data from an updated analysis of the GARNET trial, which demonstrated that dostarlimab, an investigational anti-programmed death-1 (PD-1)
Puma Biotechnology to Host Conference Call to Discuss First Quarter Financial Results
Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, will host a conference call at 1:30 p.m. PDT/4:30 p.m. EDT on Thursday, May 7, 2020, following the release of its first quarter
Pfizer Hosts Virtual-Only Annual Meeting of Shareholders
The board of directors of Pfizer Inc. (NYSE:PFE) today declared a 38-cent second-quarter 2020 dividend on the company’s common stock, payable June 5, 2020 to shareholders of record at the close of
Pfizer Hosts Virtual-Only Annual Meeting of Shareholders
The board of directors of Pfizer Inc. (NYSE:PFE) today declared a 38-cent second-quarter 2020 dividend on the company’s common stock, payable June 5, 2020 to shareholders of record at the close of
Humana and the National Quality Forum Publish Population Health Paper in the New England Journal of Medicine
Physician leaders from Humana Inc. (NYSE: HUM) and the National Quality Forum (NQF) explore the impact that social, behavioral and environmental factors – such as access to healthy foods, safe
Agilent Receives FDA Approval for PD-L1 Companion Diagnostic on Dako Omnis
Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration has approved the company’s PD-L1 IHC 22C3 pharmDx as a companion diagnostic (CDx) to identify patients
Mit EVIS X1 bringt Olympus sein bisher modernstes Endoskopiesystem auf den Markt
Die Olympus Corporation (Präsident: Yasuo Takeuchi) hat heute die Markteinführung ihres bisher modernsten Endoskopiesystems EVIS X1 bekannt gegeben. Das neue System soll mit innovativen und
Mit EVIS X1 bringt Olympus sein bisher modernstes Endoskopiesystem auf den Markt
Die Olympus Corporation (Präsident: Yasuo Takeuchi) hat heute die Markteinführung ihres bisher modernsten Endoskopiesystems EVIS X1 bekannt gegeben. Das neue System soll mit innovativen und
Mit EVIS X1 bringt Olympus sein bisher modernstes Endoskopiesystem auf den Markt
Die Olympus Corporation (Präsident: Yasuo Takeuchi) hat heute die Markteinführung ihres bisher modernsten Endoskopiesystems EVIS X1 bekannt gegeben. Das neue System soll mit innovativen und